Zoetis
is interested in partnering up on the following tender opportunity:
Tender notice title: RFI Foot and Mouth Disease Vaccine Bank
Publication date 2023/07/06
Closing date and time 2023/08/11 14:00 EDT
Zoetis details
Vaccine development, collaboration on development process
Zoetis is a multinational Animal Health Company, with products to prevent, predict and treat animal health diseases in many species. The TransBoundary and Emerging diseases Division of Zoetis VMRD has developed vaccines for many species, including vaccine for COVID-19. John Hardham is the Research Director for the Transboundary and Emerging Diseases Division of Zoetis.
First name John
Last name Hardham
Research Director VMRD Global Biologics Research
Support
Contact us directly, or find your answers using resource guides.
